Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
163 Cards in this Set
- Front
- Back
Phytomedicines
|
A medicinal product containing as active ingredients only plants, parts of plants or plant materials, or combinations thereof, whether in the crude or processed state
|
|
Rational phytotherapy
|
Therapeutic system of science-based medicine
Cure Dose-effect relationships usually apply: a larger dose will usually have a more powerful effect Clinical and pharmacological evidence of efficacy is AVAILABLE |
|
Traditional phytotherapy
|
A therapeutic system derived from the traditional use of plants
"support, improvement, alleviation..." Dose-effect relationships usually apply: a larger dose will usually have a more powerful effect Clinical and pharmacological evidence of efficacy is usually LACKING |
|
Homeopathy
|
A therapeutic system with its own concepts, not scientifically based
"Cure, support, alleviation, improvement..." The strength of the effect increases with increasing dilution (so-called "dynamisation") Scanty clinical and pharmacological evidence of efficacy |
|
Principles of homeopathy
|
A system of medicine based on the principle of "like cures like"
Uses the smallest dose possible to produce a response |
|
Basis of homeopathy treatment
|
Homeopathy works with the body's response to illness and remedies are prescribed according to the symptoms
One remedy can be used to treat several ailments One ailment may need to be treated with different remedies in different patients |
|
Homeopathy: preparation of remedies
|
1. whole plant is macerated in alcohol = mother tincture
2. if insoluble, it is finely ground and pulverized in similar proportions with powdered lactose (milk sugar) 3. 1 mL added to 9mL or 99mL of solution results in 1X or 1C potency 4. Shake vigorously in between dilutions 5. standard dilutions: 6X-30X but products of 30C or more are marketed X = 10-fold, C = 100-fold |
|
Limit to the Dilution in Remedy preparation
|
Limit = 6.023 x 10^23 which equals homeopathic concentrations of 12C or 24X (1 part in 10^24)
|
|
Cort.
|
full name (Latin) = cortex
full name (English) = bark |
|
Fol.
|
Full name (Latin) = folium, folia
Full name (English) = leaf, leaves |
|
Frct.
|
Full name (Latin) = fructus
Full name (English) = fruits |
|
Pericarp.
|
Full name (Latin) = pericarpium
Full name (English) = peel |
|
Rad.
|
Full name (Latin) = radix
Full name (English) = root |
|
Rhiz.
|
Full name (Latin) = rhizome
Full name (English) = rhizome |
|
Sem.
|
Full name (Latin) = semen
Full name (English) = seed |
|
Flor.
|
Full name (Latin) = flores
Full name (English) = flowers |
|
Components of scientific name
|
Genus species (in italics)
|
|
St. John's Wort
|
Hypericum perforatum
|
|
Cranberries
|
Vaccinium macrocarpon
|
|
Most important chemical found in grapefruit juice that contributes to drug-drug interactions
|
6',7'-dihydroxybergamottin
|
|
Marker substances
|
chemically defined constituents of herbal drugs of interest for control purposes only (may be independent of whether they have any therapeutic activity or not)
when constituents responsible for therapeutic activity unknown, assays of other determinants required (appropriateness of marker substance should be justified) |
|
Standardization
|
Defined as all measures during manufacturing process and quality control to yield reproducibility
this includes adjusting herbal drug or derived preparation to a defined content of a constituent or a group of substances with known therapeutic activity (ex = add excipients, mix herbal drugs or derived preparations) |
|
Control of Starting Materials (plants)
|
1. controlled wild collection
2. controlled post collection 3. controlled transport and storage 4. propagation for cultivation 5. cultivation 6. processing |
|
Parameters influencing extract composition: herb material
|
extractive concentration, water content, drug particle size, powder fraction
|
|
Parameters influencing extract composition: manufacturing procedure
|
extraction mode, extraction time, extraction pressure, batch size
|
|
Parameters influencing extract composition: solvent effects
|
solvent type, modifier concentration, solvent amount, flow-through rate
|
|
Parameters influencing extract composition: manufacturing plant
|
filling amount, filling height (density), static pressure
|
|
Coffee
|
Coffea arabica
|
|
Dietary Substance Health Education Act (DSHEA)
|
herbs are "dietary supplements." not drugs
|
|
DSHEA Ramifications
|
1. food safety division of the FDA regulates these products, not the drug division
2. no safety or efficacy tests required, but manufacturer is responsible for safety 3. no adverse event reporting to FDA necessary 4. no treatment claims, but "structure-function" claims are acceptable 5. to halt sales or distribution, FDA must prove that the product is "unsafe" |
|
2007 FDA Good Manufacturing Practice (GMP) requirements for dietary supplements
|
GMP ensures that all dietary supplements are manufactured consistently with respect to identity, purity, strength, and composition
Requirements include: 1. design and construction of physical maintenance plants 2. proper manufacturing operations 3. quality-control procedures 4. testing final products 5. handling customer complaints |
|
USP Certification Program
|
1. totally voluntary
2. certify ingredients 3. certify quantity of ingredients 4. will disintegrate or dissolve effectively to release nutrients for absorption into your body 5. product screened for harmful contaminants such as pesticides, bacteria, and heavy metals 6. product is manufactured using safe, sanitary and well-controlled procedures |
|
Selecting herbal supplements
|
1. look for standardized herbal supplements
2. buy only single herb products 3. beware of claims that sound too good to be true 4. be extremely cautious about herbal supplements manufactured outside the US (except most European manufacturers) |
|
Saw palmetto
|
Serenoa repens
part used: berries unique compound: steroids = beta-sitosterol, campesterol, stigmasterol |
|
Saw palmetto uses
|
1. benefit the urinary tract
2. relieve strain from painful bladder problems 3. tone the bladder by improving urinary flow 4. for treatment of BPH symptoms |
|
Saw palmetto MOA
|
BPH probably involves 5-alpha-dihydrotestosterone (DHT)
ACTS TO INHIBIT 5-alpha-reductase |
|
Isoforms of 5-alpha-reductase
|
1. 5-alpha-reductase - 1 (liver, non-genital skin, brain)
2. 5-alpha-reductase - 2 (liver, urogenital tract) |
|
Potency of DHT
|
DHT (dihydrotestosterone) is 10 times more potent than testosterone!
|
|
Saw palmetto conclusions
|
Saw palmetto provides mild to moderate improvement in urinary symptoms, flow measures
Relative to finasteride, improvements in urinary symptoms and flow measure are comparable, but fewer side effects and lower cost with saw palmetto |
|
Saw palmetto drug interactions
|
1. Androgenic drugs: therapy may decrease the effectiveness of therapeutic androgens
2. Anti-androgenic drugs: additive effects may occur with anti-androgen drugs such as finasteride 3. Anticoagulants, anti-platelets, NSAIDs: not confirmed so far |
|
Saw palmetto dose
|
1-2 grams of ground, dried, or whole berries daily
**teas prepared from saw palmetto berries are potentially ineffective because the purported active constituents are water insoluble** extract: 320 mg daily in one dose or two divided doses (160mg BID) = recommended by German expert panel, the Commission E DER (drug extract ratio): 9-12:1 |
|
DER (drug extract ratio)
|
the ratio of herbal substance to the herbal preparation
one of the most important criteria to approve the therapeutic equivalence of different herbal preparations increased DER = hard to extract compound!! |
|
Pygeum (extract of bark of an evergreen tree found in Africa)
|
Pygeum africana
part used: bark extract products should be standardized to contain 14% triterpenes and 0.5% docosanol |
|
Pygeum MOA
|
possible MOA: pygeum might inhibit growth factors
NO special safety concerns |
|
Pygeum Dose
|
75-200 mg standardized lipophilic extract (14% tripterpenes, 0.5% n-docosanol) per day has been used
some research suggests daily or BID dosing is equally effective |
|
Pygeum adverse effects
|
general: Pygeum has been well tolerated in most studies, with adverse effects similar to placebo
GI: some people may experience abdominal discomfort, including diarrhea, constipation, stomach pain, or nausea |
|
Pumpkin
|
Cucurbita pepo, Cucurbita moschata (2 different plants)
Active part: seeds (whole or crushed), seed extract oil, tablets, tea |
|
Pumpkin use
|
BPH
Proposed dose: 480mg per day (pumpkin seed extract) in 3 divided doses in combo with saw palmetto and other herbs |
|
Pumpkin adverse effects
|
electrolyte imbalance (from mild diuretic actions)
drug interactions: diuretics (potentiation of fluid loss and electrolyte imbalance) |
|
Stinging nettle
|
Urtica dioica
Parts of plant used: root Hairs that cover the plant contain acetylcholine, histamine, serotonin, leukotrienes |
|
Stinging Nettle other uses
|
adjuvant in the symptomatic treatment of arthritis, arthroses, and/or rheumatic conditions
also used as a diuretic, in inflammatory complaints of the lower urinary tract BPH |
|
Stinging nettle precaution/side effects
|
Use with caution in patients taking anti-inflammatory agents
Use with caution in patients with hyponatremia as nettle has a synergistic diuretic effect |
|
Cranberry
|
Vaccinium macrocarpon
For prevention and treatment of UTI (diuretic, antiseptic, urinary deodorizer) **rich in anthocyanins --> antioxidant, anti-inflammatory |
|
Cranberry MOA and dose
|
MOA thought previously to be urine acidification, now MOA through adhesion inhibitors
Need about 8-16 oz (240-480 mL) of pure juice (NOT DRINK OR COCKTAIL) |
|
Cranberry tablets caution
|
Dietary supplementation with cranberry concentrate tablets may increase the risk of nephrolithiasis (calcium oxalate increased)
|
|
Cranberry possible drug interaction
|
cranberry-warfarin
|
|
Cranberry dose
|
>8 oz/day of JUICE
(caution in diabetics due to sugar content) |
|
Bearberry
|
Arctostaphylos uva-ursi
part of plant used: leaves (as diuretic, astringent, antiseptic, and treatment for UTIs) |
|
Bearberry key compounds
|
ARBUTIN is the active ingredient in bearberry present in fairly high amounts (up to 10%)
HYDROXYQUINONE is a very powerful anti-microbial agent and seems to be responsible for bearberry's ability to treat UTIs |
|
Bearberry Medicinal Use
|
UTIs including cystitis, nephritis, urethritis, yeast infection, early stage of genital herpes
|
|
Bearberry Side Effects
|
nausea, vomiting (due to high tannin content)
|
|
Bearberry Dose
|
cold water infusions of the dried leaf (3g per day) correspond to 400-800 mg arbutin per day
|
|
Bearberry duration
|
until complete disappearance of symptoms, maximum of 12 weeks
|
|
Bearberry drug interactions
|
corticosteroids: may potentiate the effects of prednisolone and dexamethasone
diuretic drugs: may increase urine flow NSAIDs: may increase the anti-inflammatory activity of indomethacin |
|
Chasteberry
|
Vitex agnus
Part used: dried, ripe berries |
|
Chasteberry indication
|
menstrual irregularities including dysmenorrhea, secondary amenorrhea, oligomenorrhea, and polymenorrhea
symptoms of menopause PMS treating female infertility, increasing lactation, and treating fibrocystic breasts |
|
Chasteberry key compounds
|
vitexilactone, casticin (may also be used for standardization), rotundifuran, agnuside (usual standardized ingredient)
|
|
Standardization of chasteberry
|
many extracts are standardized to contain 0.5% agnuside or 0.6% aucubin (may be standardized to casticin content)
|
|
Chasteberry MOA
|
works similar to dopamine molecule by acting at dopamine receptor to block conversion of ATP to cAMP and therefore INHIBITING prolactin secretion
|
|
Chasteberry Dose
|
single dose each morning before breakfast throughout cycle
extract: 30-40mg/day powdered berries: 3 x per day at 500mg/dose (total 1500mg/day) 0.15-0.2mL daily of tincture (1:5 g/mL) long-term use acceptable within recommended therapeutic range |
|
Chasteberry Contraindications
|
DO NOT take with dopamine receptor antagonist/agonist
Avoid using in women undergoing in vitro fertilization use during pregnancy and lactation should be avoided |
|
Black cohosh
|
Cimifuga racemosa
Part used: root |
|
Black cohosh use
|
premenstrual complaints and dysmenorrhea as well as neurovegetative conditions related to menopause
|
|
Black cohosh key compounds
|
deoxyactein, caffeic acid, salicylic acid, formononetin
|
|
Black cohosh standardization
|
based on content of triterpenes, calculated as 27-deoxyactein
1mg of 27-deoxyactein per 20mg tablet |
|
Black cohosh MOA
|
have selective estrogen receptor modulating (SERM) effects
(estrogenic and anti-estrogenic effects) |
|
Estrogen receptors/locations
|
ER-alpha: uterus, breast, ovary, testis, kidney, and adrenal gland
ER-beta: brain, prostate, lung, bladder, intestine, bone |
|
SERMs
|
designed to act in specific ways at each of the estrogen receptor sites in different tissues
SERMs preferentially bind to ER-beta, potentially activating cardioprotective and bone-stabilizing metabolic processes SERMs down-regulate activity of ER-alpha, found in breast and uterus, and may help prevent cancer in these tissues |
|
Traditional Black cohosh dose
|
40-200mg dried rhizome daily in divided doses
|
|
Modern/recommended black cohosh dose
|
ethanol extract: equivalent to 40mg of dried rhizome/root/day
Remifemin: standardized extract where each 20mg tablet contains 1 mg triterpene glycosides, 40mg/day (2 tabs per day) |
|
Black cohosh adverse reactions
|
might cause liver disease
|
|
Black cohosh contraindications and warnings
|
contraindicated in pregnancy
anti-HTN medications allergy to aspirin in patients with known estrogen sensitive conditions interactions: atorvastatin |
|
Soybeans
|
Glycine max
observations of Asian populations: generally a diet higher in soy than America (but must start eating soy at a young age for protective effect) |
|
Beneficial components of soy
|
fatty acids:
mainly unsaturated fat minimal saturated fat plant source of omega-3 fatty acid, linoleic acid |
|
Omega ratio
|
omega-6 to omega-3 ratio should be 2:1
omega-6 family: thrombotic, inflammatory omega-3 family: less thrombotic, less inflammatory |
|
Plant derived estrogens (phytoestrogens)
|
soy or red clover--> soy (ISP) or clover isolate --> isoflavone concentrate --> genistein, daidzein, glycitin (all have weak estrogenic effects)
|
|
Phytoestrogens in human health
|
cancer preventative
post-menopausal supplement prevention of osteoporosis cardiovascular health |
|
Soy dose
|
soy protein 20-60 grams providing 34-76 mg of isoflavones daily
concentrated soy isoflavone extracts providing 35-120 mg of isoflavones daily osteoporosis: 80-90mg, in 40 grams of soy protein |
|
Red clover
|
Trifolium pratense
part used: flowering top |
|
Red clover key compounds
|
isoflavones
coumestrol (similar in structure to warfarin, increase bleeding risk) |
|
Red clover use
|
orally, red clover is used for menopausal symptoms and hot flashes (evidence is poor)
|
|
Red clover dose
|
menopausal symptoms: 40, 80, or 160mg of red clover isoflavones/day
HRT: 40-80mg of red clover isoflavones/day cholesterol: 28.5, 57, or 85.5mg of red clover isoflavones/day osteoporosis: 40mg of red clover isoflavones/day |
|
Dong quai
|
Angelica sinensis
part used: root |
|
Dong quai use
|
dysmenorrhea, PMS, and menopausal symptoms
(no phytoestrogens, coumarin derivatives) |
|
Dong quai dose
|
4.5 grams of powdered dong quai has been used daily
interactions: warfarin |
|
Wild yam
|
Disocorea species
part used: all parts grown underground |
|
Wild yam uses
|
menopausal complaints
osteoporosis precursor for commercial chemical synthesis of human steroidal hormomes |
|
Wild yam active ingredient
|
diosgenin --> progesterone
NOTE: this conversion happens synthetically but NOT in the body some products are spiked with progesterone!! |
|
Wild yam effectiveness
|
applied topically appears to be no better than placebo for reliving vasomotor symptoms
dosage: not known interactions: not known adverse effects: vomiting |
|
Garlic
|
Allium sativum
part used: bulb (all garlic for commercial use is cultivated) |
|
Modern use of garlic
|
anti-HTN
antimicrobial fibrinolytic **anti-atherogenic antithrombotic **lipid-lowering |
|
RLS of synthesis of cholesterol
|
conversion of HMG-CoA to mevalonic acid through HMG-CoA reductase
|
|
Garlic key compounds
|
Alliin: chemically stable, odorless, little physiological activity
Allicin: chemically unstable, typical garlic odor, physiologically active (RELEASED BY CRUSHING THE GARLIC) |
|
Garlic odor...why does your breath and skin stink after eating garlic?
|
The sulfur molecules that are created when garlic is smashed or chewed are absorbed into the bloodstream and lungs and escape through exhaled air and perspiration
|
|
Garlic MOA
|
inhibit HMG-CoA reductase (primary)
inhibit squalene epoxidase (in conversion of squalene to lanosterol) |
|
Garlic product formulation
|
product needs to be enteric coated to be effective!!
|
|
Aged garlic-A potent antioxidant
|
extracts of fresh garlic that are aged over a prolonged period to produce aged garlic extract (AGE) that contains antioxidant phytochemicals that prevent oxidant damage
|
|
Formation of free radicals
|
UV light
ionizing radiation smoking air pollution inflammation metabolism |
|
AGE MOA
|
AGE exerts antioxidant action by scavenging reactive oxygen species (ROS)
It protects DNA against free radical-mediated damage and mutations |
|
Garlic clinical considerations
|
side effects: odor and GI upset
active component allicin is odiferous; reduced in many products to decrease odor |
|
Garlic dose
|
tablets or capsules: 600-900mg (10mg allicin) daily
odorless formulations other than enteric-coated may be less effective!! fresh garlic: 2-5g/day (5-20 cloves) must be taken for 6 weeks - 2 months for maximal effect |
|
Garlic drug interactions
|
Norvir (ritonavir): cases of GI toxic effects
Fortovase/Invirase (saquinavir): combination results in decreased effectiveness of saquinavir warfarin: prolongs the time for blood to clot, increased risk for bleeding |
|
Red yeast rice
|
Monascus purpureus
|
|
Red yeast rice key compounds
|
major compound: monacolin K = mevinolin (similar in structure to statin)
|
|
Red yeast rice MOA
|
inhibits the action of HMG-CoA reductase
|
|
Red yeast rice dose
|
traditional: 6-9 grams/day
recommended: 1.2 grams/day |
|
Red yeast rice contraindications
|
patients who are hypersensitive or allergic to rice or yeast
|
|
Red yeast rice drug interactions
|
cholesterol-lowering medications = additive effects
grapefruit juice - HMG-CoA reductase inhibition |
|
Red yeast rice side effects
|
only mild effects have been reported: heartburn, flatulence, dizziness
|
|
Oats
|
Avena sativa
part used: seeds or oat bran (milled) |
|
Oat uses (orally)
|
hypercholesterolemia
diabetes lowering uric acid levels |
|
Oat uses (topically)
|
seborrhea
dry and itchy skin |
|
Oat key compound
|
beta-glucans --> in the bran of grasses
|
|
Oats MOA
|
(beta-glucan)
1. binds with bile acids in the gut and increasing fecal bile acid excretion 2. decreases cholesterol absorption 3. increases the viscosity of food |
|
Oats dose
|
for hypercholesterinaemia:
56-150 grams of whole oat products such as oatmeal containing 3.6-10 grams of beta-glucan |
|
Oats and FDA regulation
|
health claim: product may reduce the risk of heart disease if they contain at least 750mg of soluble fiber per serving
approximately 3 grams soluble fiber taken daily |
|
Artichoke
|
Cynara scolymus
part used: leaves of the STEM |
|
Artichoke key compounds
|
Caffeoylquinic acids
Flavonoids (eg luteolin-7-O-glycoside) Sesquiterpene lactones luteolin (most prominent), chlorogenic acid, cynarin |
|
Artichoke therapeutic indications
|
adjuvant to a low fat diet in the treatment of mild to moderate hyperlipidemia
|
|
Artichoke dose
|
320-640mg artichoke leaf extract three times daily
|
|
Artichoke MOA
|
indirect inhibition of HMG-CoA reductase
|
|
Artichoke side effects
|
mild GI disturbances, allergic reactions (in individuals sensitive to Asteracease/Compositae family plant)
also allergic contact dermatitis |
|
Artichoke safety
|
interactions with other medications: none
overdose: no toxic effects reported duration of treatment: no restriction GRAS |
|
Hawthorn
|
Crataegus species
(C. monogyna, C. laevigata) part used: leaves and flowers |
|
Hawthorn key compounds
|
Flavonoids (vitexin-4'-rhamnoside, rutin, quercetin, hyperoside)
flowers and leaves: high in flavonoids, fruits contain lowest amount |
|
Hawthorn standardization
|
range from 0.6-1.5% flavonoids, typically calculated as hyperoside
|
|
Hawthorn key compound
|
Proanthocyanidins
OPCs = oligomeric proanthocyandins |
|
Hawthorn therapeutic indications
|
preparations based on hydroalcoholic extracts: declining cardiac performance (NYHA class I or II)
herbal teas and other preparations: nervous heart complaints, support of cardiac and circulatory function |
|
Hawthorn side effects
|
GI complaints
vertigo headache sleeplessness in general, very well tolerated |
|
Hawthorn special warning
|
Self-medication is inappropriate among patients with heart failure!!
|
|
Hawthorn MOA
|
increasing force of contraction and lengthening refractory period
increasing coronary blood flow and cardiac output, and reducing oxygen consumption cardiotrophic properties: increased membrane permeability for calcium, and phosphodiesterase inhibition (intracellular cAMP increased) increased cAMP = increased coronary blood flow, vasodilation, and positive inotropic effects |
|
Hawthorn dose
|
160-900mg extract per day in 2-3 divided doses
powdered drug: 2-5 grams daily tincture: 20 drops 2-3x day herbal teas: 1-1.5 grams of drug as an infusion |
|
Hawthorn duration of treatment
|
Should be used for 4-8 weeks to determine benefit
|
|
Hawthorn interactions
|
conventional CV drug therapy
not reported |
|
Hawthorn safety
|
safe, when used short term
pregnancy and lactation: avoid using overdose: NO toxic effects reported |
|
Fish oil
|
omega-3 EPA and DHA
|
|
EPA
|
eicosapentaenoic acid (primarily from fish)
|
|
DHA
|
docosahexaenoic acid (primarily from fish)
|
|
ALA
|
alpha-linolenic (primarily from flax)
|
|
1 gram fish oil = ?
|
150 mg EPA/DHA
|
|
1 gram flax seed oil = ?
|
19.6 mg EPA/DHA
|
|
Desired omega-6 to omega-3 ratio
|
2:1
|
|
Goal omega-3 EPA/DHA consumption
|
500-650 mg per day
|
|
EPA/DHA dose
|
eat two 4 oz. servings of fatty fish per week:
providing 3500 mg EPA + DHA per week OR 496 mg of EPA + DHA per day |
|
Fish oil safety concerns
|
contamination with toxins (mercury)
|
|
EPA/DHA benefits
|
heart health
brain development brain function asthma visual acuity immune function arthritis skin and hair health |
|
Horse chestnut
|
Aesculus hippocastanum
|
|
Horse chestnut key compounds
|
terpenoid compounds:
escin (also aescin) = complex mixture of various, chemically similar triterpene glycosides **major prominent compound fatty acids coumarin derivatives (aesculin) |
|
Horse chestnut standardization
|
horse chestnut seed extract (HCSE)
16-20% triterpene glycosides calculated as aescin |
|
Horse chestnut therapeutic applications
|
treatment of chronic venous insufficiency, treatment of inflammatory conditions, skin care products, treatment of hemorrhoids
|
|
Phases of compression therapy
|
Phase I: reduction of edema and/or ulcer healing, achieved by applying non-elastic compression
Phase II: maintenance of compression, elastic compression |
|
Horse chestnut dose
|
drug or hydroalcoholic extracts = 300 to 900 mg of a 16% extract
2 or 3 x daily **in all cases, patient must continue physician-prescribed treatments including the use of supportive elastic stockings |
|
Horse chestnut safety profile
|
FDA status: unsafe herb
toxicity: attributed to the glycoside aesculin (dilation of pupils, diarrhea, vomiting, paralysis) interactions: none reported theoretically: anticoagulants |